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SINE retrotransposons of the Alu subfamily are the most numerous active mobile DNA elements in the human 
genome. Alu transcription by RNA polymerase III is subjected to tight epigenetic silencing, but activated in 
response to viral infection, genotoxic anticancer agents and other stimuli, through uncharacterized epigenetic 
switches interspersed throughout the genome. The elucidation of Alu RNA roles in cell biology and pathology 
has long been hampered by difficulties in their profiling at single-locus resolution, due to their repetitive nature. 
We recently found how to overcome this limitation by computational screening of RNA-seq data, thus opening 
the way to Alu transcriptome profiling as a novel tool to explore disease-related epigenome alterations. 
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With ~106 copies in the human genome, Alus are the most 
abundant and successful primate-specific mobile elements of 
the SINE (short interspersed elements) class, roughly 
covering 11% of the human genome. Alus are 
non-autonomous retroelements that need, for their 
amplification, trans-acting factors encoded by the LINE-1 
family of active autonomous human retroelements [1]. 
Through their novel insertions, whose rate is actually 
estimated in 1 every 20 births [2], and through non-allelic 
homologus recombination, Alus contributed to create genetic 
diversity and diseases [3]. 
All known SINEs originated from RNA polymerase (Pol) 
III-transcribed genes [4]. In particular, Alus are ~300 bp long
and are formed from 2 divergent monomers, each derived
from 7SL RNA, separated from each other by an A-rich
linker (A5TACA6), followed by a longer A-rich 3’ tail which
is necessary for retrotransposition.
Alus are autonomous transcription units, as they carry 
inside their sequence a bipartite promoter for the Pol III 
transcription machinery which is entirely located within the 
left monomer. In particular Alu transcription requires, in 
addition to RNA polymerase III, the core transcription 
factors TFIIIC and TFIIIB. The six-subunit TFIIIC complex 
recognizes A and B boxes (starting at positions +13 and +77 
of the Alu sequence, respectively). Once bound, TFIIIC 
recruits TFIIIB, composed by BRF1 and BDP1 polypeptides 
together with the TATA box binding protein (TBP), onto a 
~50 bp region located immediately upstream of the 
transcription start site. TFIIIB then directs the assembly of 
Pol III for transcription initiation. In complete Alu elements, 
elongating Pol III goes through both the left and right 
monomers and the terminal poly(A) region, and it does not 
terminate transcription until it encounters a specific 
termination signal (either canonical or non-canonical) [5, 6]. 
The terminator (usually a run of at least four Ts on the 
coding strand) can be located at variable distances 
downstream of the poly(A): as a consequence, Alu 
transcripts are very similar to each other in sequence up to 
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the poly(A), but they may carry 3’ trailer sequences strongly 
differing from each other in both sequence and length. 
Once thought to be part of the so called “junk DNA”, 
Alu’s cis and trans regulatory roles have been uncovered 
over time. Alu elements have been found to regulate the 
expression of protein coding genes by acting as silencers, 
insulators, promoters and enhancers; they also can provide, 
due to accumulation of mutations in their sequence and A to 
I pre-mRNA editing, new splice (Alu exonization) and 
polyadenylation sites [7-9]. 
As to trans roles, Pol III Alu transcripts have started to 
attract increasing interest in the last ten years as potential 
regulators of Pol II-dependent gene expression, either at the 
post-transcriptional level through antisense strategies [10] or 
at the transcriptional level through Pol II binding and 
modulation [11]. Alu Pol III transcripts can also act as 
translation regulators [12, 13], while Alu sequences embedded 
in mRNA 3’ UTRs and ncRNA sequences can be part of 
STAU1-mediated mRNA decay [14] and transcriptional 
regulation [15]. 
Despite the abundance of Alu elements in the genome, and 
the generally high efficiency with which Pol III transcribes 
its target genes [16], the cellular levels of Pol III-synthesized 
Alu RNAs are usually very low in normal conditions and, 
accordingly, most Alus are not occupied by the Pol III 
transcription machinery in human cells [17]. Alu transcription 
by Pol III is thought to be limited by epigenetic silencing 
mainly involving histone methylation [18], but a satisfactory 
picture of Alu expression regulation at the transcriptional 
level is still lacking [19]. In particular, early and recent studies 
have shown that Alu transcription by Pol III may be 
up-regulated in response to different types of signal like viral 
infection [20], heat shock [21], nuclear receptor stimulation [22], 
growth signals [23], but the involved molecular mechanisms 
are still largely unknown. It must be noted, however, that the 
bulk of Alu RNAs are the product of Pol II (not Pol III) 
transcriptional activity. Indeed, since Alu elements are 
preferentially located in gene-rich regions, particularly within 
introns and 3’UTRs of Pol II genes [24], the majority of 
Alu-containing RNAs is due to either primary nuclear 
transcripts (hnRNAs) or mature mRNAs. Therefore, genuine 
Pol III-derived Alu transcripts are difficult to be 
distinguished from those that are hosted within longer Pol 
II-synthesized RNA molecules. 
Previous studies aimed at identifying Pol III Alu 
transcripts and the corresponding source elements exploited 
various combination of size fractionation, C-RACE (rapid 
amplification of cDNA ends) and sequencing and, more 
recently, genome-wide chromatin immunoprecipitation 
followed by massive parallel sequencing (ChIP-seq) against 
Figure 1. Schematic description of flanking region filter allowing to identify Pol III-dependent Alu transcripts from 
RNA-seq data. For each Alu a 1050 bp region was considered, consisting of: a central, 350 bp segment having the Alu body at its 
center; a 5’segment extending 350 bp upstream of the central segment, and a 3’ segment extending 350 bp downstream of the 
central segment. The reads corresponding to Alu bodies will map to the central segment, while most of the reads corresponding to 
Alu 3’ extensions past the terminal poly(A) will map to the 3’ segment. No reads from genuine Alu transcripts should map to the 5’ 
segment. If this occurs the Alu will be discarded, as exemplified in the lower part of the Figure. Taking 500 nt as the typical Alu 
transcript length, we can predict that its ~150 3’-terminal nucleotides will map to the 3’ segment (as we consider that the first 350 nt 
will map to the central segment). As a consequence, the 3’ segment will be typically covered by transcripts for no more than half of 
its 350-bp extension (while the central segment, containing the Alu body, is expected to be covered by transcripts along its whole 
extension). Therefore, transcripts generating on the 3’segment a signal higher than the half of the central segment signal are 
considered to be too long for Pol III Alu transcripts [29].  
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the Pol III machinery [25-27]. While the first kind of studies 
give us clear evidence of transcription but are difficult to 
carry out on a genome-wide scale (low throughput approach), 
the latter ones do not provide direct evidence of transcription 
since the binding of the Pol III transcription machinery does 
not necessarily correlate with transcriptional activity [28]. 
Most Alu RNAs have several distinctive features such as 
differences in the body sequence due to accumulation of 
mutations, length and sequence differences in the terminal 
poly-A tail, and unique 3’ trailer sequence located between 
the 3’ end of Alu conserved body and the closest downstream 
Pol III terminator [1]. In a recently published study, we 
exploited these sequence hallmarks (distinguishing most 
individual Alus from each other), together with the 
increasing availability of transcriptomic data deriving from 
next-generation sequencing experiments, to overcome 
limitations of previous approaches, by devising a 
bioinformatic pipeline which uses RNA-seq data to identify 
Pol III Alu transcripts and the corresponding source elements 
of transcription [29]. Optimal performance of this pipeline 
requires long (≥75 nt) paired-end reads because, even if most 
Alu RNAs are unique throughout their entire sequences, 
shorter reads from RNA-seq experiments often fail to align 
uniquely to the human genome due to the repetitive nature of 
these elements. 
Once the reads have been aligned to the human reference 
genome (hg19), we count the number of uniquely mapped 
paired-end reads in each annotated Alu element, retaining 
only those with more than 10 reads count uniquely mapped. 
To filter out passenger Alu RNA embedded within Pol II 
transcripts, we apply a filter based on the level of spurious 
expression signal upstream and downstream the Alu element 
(Figure 1). 
By applying the Alu RNA search pipeline to a number of 
ENCODE RNA-seq datasets (CSHL Poly(A)+ and PolyA(-) 
long RNA-seq datasets of 7 cell lines) [30] we found 1295 
unique putative Alu transcripts of which approximately 9% 
expressed in at least 3 cell lines, while ~75% of them turned 
out to be cell type-specific [29]. Thus, despite the tiny fraction 
(0,01%) of Alu loci found to be expressed among the ~1.1 
million Alus  in the human genome, these results suggest 
that Pol III-transcribed Alu RNAs derive from a small subset 
(~100) of ubiquitously expressed Alu elements, and from a 
larger subset (~1000) that tends to vary by cell type, state, 
growth conditions. This observation is in agreement with the 
results of recent human transcriptome analyses, showing a 
marked cell line specificity as the main feature of RNAs 
transcribed from repeated regions, including LINEs and 
SINEs [30]. A heatmap visualization of cell lineage-specific 
Alu expression is reported in Figure 2.  
The ability to profile Alu expression at single-locus 
resolution opens novel interesting possibilities. As reminded 
above, a remarkable feature of Alu RNA profiles is that they 
most likely reflects the operation of epigenetic switches at 
the corresponding genomic loci. Alu expression profiles thus 
have the potential to directly and precisely reveal altered 
epigenomic states that might accompany pathological states, 
such as malignancies. As an example of this possibility, 
demethylation (and thus likely derepression) at an Alu locus 
was shown to activate an associated miRNA locus producing 
a miRNA acting as an oncogene endogenous silencer [31]. Alu 
expression profiles at single-locus resolution might lead to 
identify regions of particularly permissive chromatin whose 
resident genes might be deregulated in concomitance with 
Alu deregulation. More generally, Alu RNA profiles might 
represent a novel type of highly specific molecular signature 
for cancer and other diseases. 
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Figure 2. Cell lineage-specificity of Alu expression. Alu expression heatmaps could be generated 
from ENCODE RNAseq data [29], thus allowing for data clustering and for estimation of the degree of 
cell type-specificity of expressed Alus. Shown is the heatmap of expression-positive Alus from the 
indicated cell lines, sorted on the basis of cell-line specific expression, displaying ubiquitously 
expressed/non-specific Alus (left), and tissue-specific Alus (right). 
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